Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

47 Resultados de la búsqueda.

CALGB: 80101 TREATMENT FORM NCT00052910

- 3/6/15 - 1 formulario, 2 itemgroups, 21 items, 1 idioma

Itemgroups: CALGB clinical trial administrative data, Treatment Summary

CALGB: 80101 TREATMENT FORM Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer NCT00052910 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9DA6CD3D-F968-5976-E034-080020C9C0E0

CALGB: 80101 ON-STUDY FORM NCT00052910

- 3/6/15 - 1 formulario, 5 itemgroups, 35 items, 1 idioma

Itemgroups: CALGB clinical trial administrative data, Tumor Diagnosis, LAB DATA AT PROTOCOL ENTRY, GASTRIC RESECTION DATA, HISTOLOGY & STAGING DATA

CALGB: 80101 ON-STUDY FORM NCT00052910 Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9DA712C5-6067-535F-E034-080020C9C0E0

CALGB: 80101 Adverse Event Form NCT00052910

- 3/6/15 - 1 formulario, 3 itemgroups, 21 items, 1 idioma

Itemgroups: CALGB clinical trial administrative data, Expected Adverse Events, CCRR MODULE

CALGB: 80101 Adverse Event Form NCT00052910 Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A35FEF5E-9EE9-11AA-E034-080020C9C0E0

Eligibility Localized Squamous Cell Carcinoma of the Esophagus NCT02017600

- 2/7/20 - 1 formulario, 2 itemgroups, 17 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus; ODM derived from: https://clinicaltrials.gov/show/NCT02017600

Eligibility Esophageal Squamous Cell Carcinoma Resectable NCT01688700

- 16/12/19 - 1 formulario, 2 itemgroups, 17 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01688700

Eligibility Esophageal Squamous Cell Carcinoma NCT01822613

- 16/12/19 - 1 formulario, 2 itemgroups, 9 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC); ODM derived from: https://clinicaltrials.gov/show/NCT01822613

Eligibility Esophageal Carcinoma NCT01937208

- 14/12/19 - 1 formulario, 2 itemgroups, 16 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Comparable Study of Different Radiation Dose in Esophageal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01937208

Eligibility Esophageal Carcinoma NCT01034683

- 13/12/19 - 1 formulario, 2 itemgroups, 14 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01034683

Eligibility Esophageal Squamous Carcinoma NCT01752205

- 8/12/19 - 1 formulario, 2 itemgroups, 26 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01752205

Eligibility Stage IV Esophageal Squamous Cell Carcinoma NCT02034968

- 11/7/19 - 1 formulario, 2 itemgroups, 11 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02034968

Eligibility Stage IV Esophageal Squamous Cell Carcinoma NCT02011594

- 11/7/19 - 1 formulario, 2 itemgroups, 13 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02011594

Eligibility Squamous Cell Carcinoma of Esophagus NCT02041819

- 9/7/19 - 1 formulario, 2 itemgroups, 18 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus; ODM derived from: https://clinicaltrials.gov/show/NCT02041819

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.